AzTrials
AzTrials

Intermittent Urethral CatheterizationNCT04033913

What Are the Criteria for the Patient's Choice of Sel-catheterization Catheter

An observational study of Intermittent Urethral Catheterization, run by Gérard Amarenco at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate which are the most important criteria guiding the choice of the catheter for the patient to perform clean intermittent self catheterization. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intermittent Urethral Catheterization
What is being tested?
Self questionnaire
How many people
73 participants
Where
1 siteFrance
Study dates
12 Nov 2018to 30 Sep 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults patients who have successfully perform self-catheterization during a day hospital in a neuro-urology department

Who may be able to join

  • Adults patients who have successfully perform self-catheterization during a day hospital in a neuro-urology department

Who cannot join

  • patient who does not speak French
  • refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • department of Neuro-Urology, Hôpital Teno

    Paris, 75020

Other trials in France

About this study

The aim of this study is to evaluate which are the most important criteria guiding the choice of the catheter for the patient to perform clean intermittent self catheterization.

Read the detailed description

Management of voiding dysfunction has been revolutionized by the practice of clean intermittent self-catheterization (CISC) described by Lapides. It is nowadays the gold standard for the treatment of urinary retention in neurogenic bladders. But increasingly, CISC is prescribed to patients with non-neurogenic lower urinary tract symptoms (LUTS). Several studies have demonstrated an improvement in quality of life in patients under CISC. There are several indications for CISC in older adults, either in neurological condition (myelopathy following neck osteoarthritis, lumbar spinal stenosis, multiple sclerosis (MS), etc…) or not (bladder outlet obstruction, underactive detrusor, etc…).

The arrival of hydrophilic catheters has revolutionized management, reducing the risk of traumatic and infectious complications and facilitating their use. Many catheters are now available, and the choice of catheter may depend on different factors: grip disorder, ease of use, design and packaging, discomfort or pain when testing a specific material, specific anatomical conditions (male Tiemann or olive tip), longer catheter length in case of imperfect emptying, explanations given on how to use the catheter... Thus, if the doctor and the nurse involved in the patient's therapeutic education in self-catheterization will guide the choice of the catheter according to medical criteria and the patient's physical capacities, the patient remains an active participant in the choice of the model. Making the patient an actor and decision-maker can also improve adherence to treatment.

The aim of this study is to evaluate which are the most important criteria guiding the choice of the catheter for the patient.

In this study, the investigators develop a questionnaire based on expert meetings and literature review of the criteria that guide the choice of the catheter.

Five areas are explored: catheter design, catheter length, comfort of using the catheter, nurse's explanations, easy to transport and dispose of the catheter.

The importance of each criterion is rated by a 4-level likert scale (strongly disagree, somewhat disagree, somewhat agree, strongly agree) and patient have to report the most important criterion for the choice of the catheter.

Number of types of catheter showed and tried are reported, and if they chose the first, second, are two types of catheter. The questionnaire is completed at the end of a day hospital to learn to perform CISC

Data collected are:

  • Age
  • Sex
  • Etiology of urinary disorders
  • Score of the Pencil and Paper Test
  • Functional Independence Measure score
  • Nine Hold Peg Test over 18
  • "Tinetti Mobility Test" score
  • sensory hand problems assessed by Weber test

Statistical analyses will be performed with the R software for Windows (Rx64 3.2.3, R Foundation for Statistical Computing, Vienna, Austria). Descriptive data will be presented as means with standard deviation for continuous data and as medians with range for ordinal data and data not normally distributed.

Differences between the choosing criterion and the patients' characteristics will be assessed using analysis of variance or Chi2 tests. A p value of less than 0.05 will be considered statistically significant.

This study was approved by the local ethics review board.

Being tested
Self questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self questionnaireOther

    Patients who have successfully perform self-catheterization complete a self questionnaire on the importance of each criterion in choosing the catheter they have made.

Study groups in NCT04033913
Study groupRoleWhat they receive
Adult patient learning self-catheterizationPatients who have successfully perform self-catheterization during a day hospital in a neuro-urology department complete a questionnaire validated by experts on the different criteria that guided the final choice of the catheter
Receives: Other: Self questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The criterion of the created questionnaire for the choice of the catheter designated by the patient as the most important (rate of patients who identified each criterion as the most important)

    patients must identify the most important criterion among the 5 proposed in the questionnaire created: catheter design; catheter length; comfort to handle the catheter; nurse's explanations; discretion for transport and disposal of the catheter.

    Only one answer is accepted.

    Measured: 1 day

Secondary outcomes (1)
  1. Importance for the choice of catheter of each of the 5 criteria of the questionnaire created, using a 4-level likert scale

    the importance of each criterion (catheter design; catheter length; comfort to handle the catheter; nurse's explanations; discretion for transport and disposal of the catheter) is rated by a 4-level likert scale (strongly disagree, somewhat disagree, somewhat agree, strongly agree)

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2019
  2. Study start12 Nov 2018
  3. Primary completion10 Aug 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
73 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04033913
Sponsor's protocol ID
GRC-01 GREEN
Status last verified
Nov 2019
First submitted
20 Jul 2019
Last updated
29 Nov 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Intermittent Urethral Catheterization, run by Gérard Amarenco at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The criterion of the created questionnaire for the choice of the catheter designated by the patient as the most important (rate of patients who identified each criterion as the most important) (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in